4//SEC Filing
Malenka Robert C. 4
Accession 0002021198-25-000006
CIK 0001770069other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:15 PM ET
Size
11.8 KB
Accession
0002021198-25-000006
Insider Transaction Report
Form 4
Malenka Robert C.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2025-10-27+139,610→ 139,610 totalExercise: $17.00Exp: 2035-10-26→ Voting Common Stock (139,610 underlying) - Award
Voting Common Stock
2025-10-27+34,390→ 399,671 total - Conversion
Voting Common Stock
2025-10-28+3,895→ 31,672 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2025-10-28−65,477→ 0 total(indirect: See footnote)→ Voting Common Stock (3,895 underlying)
Footnotes (5)
- [F1]Represents a restricted stock unit ("RSU") award. 25% of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- [F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- [F3]The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
- [F4]The shares are held by the Robert C. Malenka Living Trust U/A DTD 08/21/2012, of which the Reporting Person is the sole trustee and has voting and dispositive power.
- [F5]1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
MapLight Therapeutics, Inc.
CIK 0001770069
Entity typeother
Related Parties
1- filerCIK 0002021198
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:15 PM ET
- Size
- 11.8 KB